Evolent Health ( NYSE: EVH ) is scheduled to announce Q2 earnings results on Thursday, August 8th, after market close. The consensus EPS Estimate is $0.25 (+78.
6% Y/Y) and the consensus Revenue Estimate is $636.41M (+35.7% Y/Y).
Over the last 2 years, EVH has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time. Over the last 3 months, EPS estimates have seen 3 upward revisions and 6 downward. Revenue estimates have seen 12 upward revisions and 0 downward.
More on Evolent Health Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade) Evolent Health, Inc. (EVH) Q1 2024 Earnings Call Transcript Evolent to buy AI utilization management products from Machinify Engaged Capital's Q1 moves: adds Envestnet, trims Shake Shack, others Seeking Alpha’s Quant Rating on Evolent Health.